✳flâneur — a map of the web's best reading

Anatomy of a Biotech Business Development Deal | Andreessen Horowitz

a16z.com · 5,821 words · saved by 1 readers

Biotech founders face a variety of challenges in building a successful startup. Beyond confronting daunting scientific and technical hurdles, they must develop a strategy to ensure their technology has a compelling business model and is focused on the right problems. Also, they need a plan for how the tech will go the distance — i.e., when to go it alone or seek to partner. Why partner? Biotech startups have limited resources and experience. Teaming up with a large biopharma company is often a great strategy for accelerating time to validation and having a real impact on patients. At a basic level, these partnerships marry the scientific innovation that thrives in startups with the deep drug development expertise of established companies, ultimately delivering innovative new drugs to patients faster. But there’s a wide chasm between wanting to partner and signing on the dotted line so you can get to the fun stuff: the science. Getting that first deal can be difficult, especially for fi

Anatomy of a Biotech Business Development Deal | Andreessen Horowitz Bio + Health Anatomy of a Biotech Business Development Deal Jorge Conde and Becky Pferdehirt Posted January 25, 2022 Subscribe Share Share Email X LinkedIn Facebook Hacker News WhatsApp Flipboard Reddit Share Share Email X LinkedIn Facebook Hacker News WhatsApp Flipboard Reddit Biotech founders face a variety of challenges in building a successful startup. Beyond confronting daunting scientific and technical hurdles, they must develop a strategy to ensure their technology has a compelling business model and is focused on the

Explore this link on the map →

saved by

related reading